Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.

Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.
复制标题

DOI:
10.1021/acs.jmedchem.9b01900
复制
发表时间:
2020-03-26
影响因子:
7.3
通讯作者:
Rong L
Rong L
中科院分区:
医学1区
文献类型:
--
作者:
Gaisina IN;Peet NP;Cheng H;Li P;Du R;Cui Q;Furlong K;Manicassamy B;Caffrey M;Thatcher GRJ;Rong L

文献摘要

参考文献

被引文献

相似文献

疫苗接种是控制季节性流感感染最普遍的预防手段。然而,针对流行毒株的有效疫苗通常需要至少 6 个月的时间才能开发出来。因此,需要新的治疗方案来急性治疗流感感染,以控制这种病毒并防止流行病/大流行的发展。我们发现了速效、口服生物可利用的酰化 4-氨基哌啶,具有针对病毒血凝素 (HA) 的有效作用机制。我们的数据表明这些化合物是甲型流感病毒的有效进入抑制剂。我们提出的对接研究表明这些抑制剂在 H5N1 上有一个 HA 结合位点。当在流感病毒 H1N1 (A/Puerto Rico/8/1934) 或 H5N1 (A/Vietnam/1203/2004) 株以及具有最常见 H274Y 突变的奥司他韦耐药株的感染性测定中进行评估时,化合物 16 显示病毒滴度显着降低。此外,化合物16在体外与奥司他韦表现出显着的协同活性。
Vaccination is the most prevalent prophylactic means for controlling seasonal influenza infections. However, an effective vaccine usually takes at least 6 months to develop for the circulating strains. Therefore, new therapeutic options are needed for the acute treatment of influenza infections to control this virus and prevent epidemics/pandemics from developing. We have discovered fast-acting, orally bioavailable acylated 4-aminopiperidines with an effective mechanism of action targeting viral hemagglutinin (HA). Our data show that these compounds are potent entry inhibitors of influenza A viruses. We present docking studies that suggest an HA binding site for these inhibitors on H5N1. Compound 16 displayed a significant decrease of viral titer when evaluated in the infectious assays with influenza virus H1N1 (A/Puerto Rico/8/1934) or H5N1 (A/Vietnam/1203/2004) strains and the oseltamivir-resistant strain with the most common H274Y mutation. In addition, compound 16 showed significant synergistic activity with oseltamivir in vitro.
DOI: 10.3389/fmicb.2016.00450
发表时间: 2016
影响因子: 5.2
作者:
Alame MM;Massaad E;Zaraket H
通讯作者: Zaraket H
DOI: 10.1128/aac.00581-10
发表时间: 2010-09-01
影响因子: 4.9
作者:
Nguyen, Ha T.;Sheu, Tiffany G.;Gubareva, Larisa V.
通讯作者: Gubareva, Larisa V.
DOI: 10.1186/1743-422x-6-75
发表时间: 2009-06-08
期刊: Virology journal
影响因子: 4.8
作者:
Manicassamy B;Rong L
通讯作者: Rong L
DOI: 10.1016/s0264-410x(03)00074-4
发表时间: 2003-05-01
期刊: VACCINE
影响因子: 5.5
作者:
Kemble, G;Greenberg, H
通讯作者: Greenberg, H
DOI: 10.1128/jcm.01190-10
发表时间: 2010-11-01
影响因子: 9.4
作者:
Mehta, Tejal;McGrath, Eric;Alangaden, George J.
通讯作者: Alangaden, George J.